We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Half-Life and Safety of Canakinumab in Pediatric Patients: Comment on the Article by Ilowite et al.
- Authors
Brunner, Hermine; Lomax, Kathleen Graham; Levy, Stephane
- Abstract
A letter to the editor is presented in response to the article "Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis" by N. T. Ilowite and colleagues in the previous issue is presented.
- Subjects
TREATMENT of arthritis; THERAPEUTIC use of monoclonal antibodies; ARTHRITIS; MONOCLONAL antibodies; PEDIATRICS; RHEUMATOLOGY
- Publication
Arthritis & Rheumatology, 2015, Vol 67, Issue 3, p857
- ISSN
2326-5191
- Publication type
Article
- DOI
10.1002/art.38992